TABLE 1.
Clinical and laboratory features of the patients.
| Feature | N = 112 |
| Age [years] | |
| Median (range) | 68(34−92) |
| Sex N (%) | |
| Males | 58 (51.8) |
| Females | 54 (48.2) |
| Ferritin [ng/ml] | |
| Median (range) | 260.5(53−943.5) |
| Underlying diseases N (%) | |
| HBV hepatitis | 6 (5.4) |
| HCV hepatitis | 11 (9.8) |
| Alcoholic hepatitis | 6 (5.4) |
| NAFLD/NASH | 6 (5.4) |
| Cryptogenic cirrhosis | 1 (0.9) |
| Cirrhosis N (%) | 17 (15.2) |
| Adjuvant chemotherapy N (%) | 36 (32.1) |
| Recurrence N (%) | 60 (53.6) |
| Exitus N (%) | 73 (65.2) |
HBV, hepatitis B virus; HCV, hepatitis C virus; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis.